Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Verastem (VSTM) Common Equity: 2018-2024

Historic Common Equity for Verastem (VSTM) over the last 6 years, with Dec 2024 value amounting to -$28.9 million.

  • Verastem's Common Equity fell 240.38% to -$15.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$15.5 million, marking a year-over-year decrease of 240.38%. This contributed to the annual value of -$28.9 million for FY2024, which is N/A change from last year.
  • Latest data reveals that Verastem reported Common Equity of -$28.9 million as of FY2024, which was down 160.97% from $47.4 million recorded in FY2022.
  • Verastem's 5-year Common Equity high stood at $115.3 million for FY2020, and its period low was -$28.9 million during FY2024.
  • Its 2-year average for Common Equity is $9.2 million, with a median of $9.2 million in 2022.
  • In the last 5 years, Verastem's Common Equity soared by 1,506.83% in 2020 and then tumbled by 45.88% in 2022.
  • Verastem's Common Equity (Yearly) stood at $115.3 million in 2020, then fell by 24.04% to $87.6 million in 2021, then plummeted by 45.88% to $47.4 million in 2022, then reached -$28.9 million in 2024.